Some types of surgery benefit from the use of biomedical meshes to support reconstruction. For instance:
- hernia repair
- repair of cardiac aneurisms
- hand orthopedic procedures
- aesthetic procedures
Hernia patches alone account for a 4B USD market.
The ideal material has high mechanical strength, is an excellent scaffolding material for tissue regrowth, and degrades at a predictable rate.
Current solutions provide only one or two of these properties: Synthetic materials are strong but do not degrade, leading to pain and frequently revision surgery. Biological materials degrade naturally but unpredictably and are prohibitively expensive..
In addition, working with either synthetic or biomaterial patches is challenging for the surgeon as it must be shaped with scissors ahead of time, then adapted during surgery.
Poltiss has developed a patented patch technology called PhotoBioCure™ that requires no pre-surgery customization, has superior scaffolding properties, exhibits predictable degradation and can be applied via a laparoscopic procedure.
Instead of the typical mesh materials used in traditional surgeries, PhotoBioCure™ starts as a viscous liquid that is injected directly onto the surgical field. The liquid is exposed to a UV light, causing it to cure within seconds.
We have successfully demonstrated PhotoBioCure™ in animal trials. Next step is preclinical trials and, in parallel, obtaining 510K regulatory approval. We intend to complete both these critical milestones by 2019.